COVID-19 and psoriasis: Recommendation for patients on regular infliximab therapy.
Dermatol Ther
; 33(6): e14472, 2020 Nov.
Article
in English
| MEDLINE | ID: covidwho-894746
ABSTRACT
During COVID-19 outbreak hospitals were congested and infliximab was interrupted. Thus, we performed this observational study to understand the consequent burden of complications in these special cluster of psoriatic patients. We followed up 56 psoriatic patients who were receiving Infliximab treatment by telephone. The majority of patients had lesions exacerbation, accompanied by anxiety emotion. It is suggested that reserving common drugs for psoriasis at home is necessary. Besides, telemedicine should be advocated as a main medical visit mode during the outbreak of COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Psoriasis
/
Telemedicine
/
Dermatologic Agents
/
Infliximab
/
COVID-19
/
Health Services Accessibility
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Dermatol Ther
Journal subject:
Dermatology
Year:
2020
Document Type:
Article
Affiliation country:
Dth.14472
Similar
MEDLINE
...
LILACS
LIS